股票 › PCRX
派西拉生物科学 PCRX
美股市值排名 #2962
$36.43 +$0.01 (+0.03%)
休市 · Nov 6, 10:00 pm ET · 最新盘后价 $36.43 0.00%
开盘$36.42
昨收$36.42
当日区间$36.42 – $36.45
成交量537.1K
市值$1.46B
市盈率（TTM）39.2
股息率–
PCRX 相关新闻
匹配 Pacira BioSciences 或代码 PCRX 的头条新闻，按最新排序。
- Leerink Partners Initiates Pacira BioSciences(PCRX.US) With Hold Rating, Announces Target Price $28
- Truist Financial Maintains Pacira BioSciences(PCRX.US) With Buy Rating
- H.C. Wainwright Maintains Pacira BioSciences(PCRX.US) With Buy Rating, Maintains Target Price $38
- Needham Maintains Pacira BioSciences(PCRX.US) With Buy Rating, Raises Target Price to $33 正面
- Truist Financial Initiates Pacira BioSciences(PCRX.US) With Buy Rating
- Truist Financial Upgrades Pacira BioSciences(PCRX.US) to Buy Rating, Raises Target Price to $30 正面
- Barclays Maintains Pacira BioSciences(PCRX.US) With Hold Rating, Maintains Target Price $25
- Pacira Pharmaceuticals (PCRX) Receives a Sell From J.P. Morgan
- J.P. Morgan Maintains Pacira BioSciences(PCRX.US) With Sell Rating, Maintains Target Price $23
- Needham Maintains Pacira BioSciences(PCRX.US) With Buy Rating, Maintains Target Price $32
- Needham Maintains Pacira BioSciences(PCRX.US) With Buy Rating, Raises Target Price to $32 正面
- Analysts' Top Healthcare Picks: Pacira Pharmaceuticals (PCRX), Cadrenal Therapeutics, Inc. (CVKD)
- H.C. Wainwright Reaffirms Their Buy Rating on Pacira Pharmaceuticals (PCRX)
- Needham Maintains Pacira BioSciences(PCRX.US) With Buy Rating, Maintains Target Price $30
- Barclays Maintains Pacira BioSciences(PCRX.US) With Hold Rating, Cuts Target Price to $25 负面
暂无评论——快来第一个聊聊 PCRX。
登录后参与讨论。